Focal cerebral ischemia induces Alzheimer’s disease-like pathological change in rats

Abstract

The changes in the tau protein phosphorylation and expression of bcl-2, and bax in rat parietal cortex neurons after focal cerebral ischemia-reperfusion (I/R) were explored, and the relationship between the tau protein phosphorylation and the expression of bax or apoptosis was clarified in order to elucidate the relationship between cerebral infarction and Alzheimer’s disease. The rat focal cerebral I/R model was induced by occlusion of the right middle cerebral artery using the intraluminal suture method. The level of tau protein phosphorylation at Ser396, Ser404, Tyr231, Ser199/202 sites and the expression of bcl-2, bax and total tau 5 in rat parietal cortex during focal cerebral ischemia/reperfusion were detected by Western blot. The relationship between the tau protein phosphorylation and the expression of bax, or apoptosis was examined by TUNEL method and double-labeling immunofluorenscence method. The results showed that the level of tau hyperphosphorylation at Ser199 / 202, Ser396, Ser404, Tyr231 sites and the expression levels of bcl-2, and bax were significantly higher in I/R group than in the sham group, but the ratio of bcl-2/bax was decreased. Neuronal apoptosis, bax expression and the tau protein hyperphosphorylation were co-localized. It is suggested that Alzheimer’s disease-like pathological changes occur after cerebral I/R. The highly abnormal phosphorylation of tau protein plays a key role in cerebral I/R-induced apoptosis. The cerebral infarction may contribute to Alzheimer’s disease occurrence and development.

Keywords

cerebral ischemia / Alzheimer’s disease / tau protein / phosphorylation / apoptosis / bcl-2 / bax

References

[1] KalariaR.. Similarities between Alzheimer’s disease and vascular dementia. J Neurol Sci, 2002, 203–205(29–34): 29-34

[2] TatemichiT.K., DesmondD.W., MayeuxR., et al.. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology, 1992, 42(6): 1185-1193

[3] TatemichiT.K., PaikM., BagiellaE., et al.. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology, 1994, 44(10): 1885-1891

[4] De la TorreJ.C.. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol, 2004, 3(3): 184

[5] GötzJ., ChenF., van DorpeJ., et al.. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science, 2001, 293(5534): 1446-1447

[6] KobayashiK., NakanoH., HayashiM., et al.. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer’s disease. J Neurol Sci, 2003, 208(1–2): 17-24

[7] MacGibbonG.A., LawlorP.A., SirimanneE.S., et al.. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease hippocampus. Brain Res, 1997, 750(1–2): 223-234

[8] TortosaA., LopeaE., FerrerI.. Bcl- 2 and Bax protein expression in Alzheimer’s disease. Acta Neuropathol, 1998, 95(4): 407-412

[9] ZhaoH., YenariM.A., ChengD., et al.. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem, 2003, 85(4): 1026-1036

[10] ZhuY., PrehnJ., ClumseeC., et al.. The beta-2-adrnoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience, 1999, 90(4): 1255-1263

[11] LongaE.Z., WeinsteinP.R., CarlsonS., et al.. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20(1): 84-91

[12] ShawnN.W., VladimirC.H., DavidF.C., et al.. Interaction between a rat model of cerebral ischemia and β- amyloid toxicity. Inflammatory Responses. Stroke, 2005, 36(1): 107-112

[13] LiJ., WangY.J., ZhangM., et al.. Effect of cerebral ischemia on the expression of abnormally phosphorylated tau protein in cortical and hippocampal neurons of AD rats. Chongqing Med (Chinese), 2008, 37(7): 678-682

[14] EhehaltR., KellerP., HaassC., et al.. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol, 2003, 160(1): 113-123

[15] HonigL.S., KukullW., MayeuxR., et al.. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology, 2005, 64(3): 494-500

[16] BellewK.M., PigeonJ.G., StangP.E., et al.. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord, 2004, 18(4): 208-213

[17] KopkeE., TungY.C., ShaikhS., et al.. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem, 1993, 268(32): 24 374-24 384

[18] Cardona-GómezG.P., Arango-DavilaC., Gallego-GómezJ.C., et al.. Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit in postischemic hippocampus. Neuroreport, 2006, 17(12): 1337-1341

[19] IkedaK., AkiyamaH., AraiT., et al.. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?. Neurosci Lett, 2000, 284(3): 187-189

[20] WenY., YangS.H., LiuR., et al.. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Research, 2004, 1022(1–2): 30-38

[21] GongC.X., WegielJ., LidskyT., et al.. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res, 2000, 853(2): 299-309

[22] RothK.A.. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol, 2001, 60(9): 829-838

[23] KatsujiK., HiroyukiN., MasahiroH., et al.. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer’s disease. J Neurol Sci, 2003, 208(1–2): 17-24

[24] MacGibbonG.A., LawlorP.A., SirimanneE.S., et al.. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease hippocampus. Brain Res, 1997, 750(1): 223-234

[25] GuiseS., BraguerD., CarlesG., et al.. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblstoma cells. Neurosci Res, 2001, 63(3): 257-267

[26] TortosaA., LopeaE., FerrerI., et al.. Bcl- 2 and Bax protein expression in Alzheimer’s disease. Acta Neuropathol, 1998, 95(4): 407-412

[27] ChenL.Q., WeiJ.S., LeiZ.N., et al.. Induction of Bcl-2 and Bax was related to hyperphosphorylation of Tau and neuronal death induced by okadaic acid in rat brain. Anat Rec A Discov Mol Cell Evol Biol, 2005, 287A(2): 1236-1245

[28] EberspacherE., WernerC., EngelhardK., et al.. The effect of hypothermia on the expression of the apoptosis-regulating protein Bax after incomplete cerebral ischemia and reperfusion in rats. J Neurosurgy Anesthesiol, 2003, 15(3): 200-208

[29] AmemiyaS., KamiyaT., NitoC., et al.. Anti-apoptotic and neuro-protective effect of edaiavone following transient focal ischemia in rats. Eur J Pharmacol, 2005, 516(2): 125-130